| Name | Recombinant Human KIR2DL5/CD158f Fc Chimera Protein, CF |
|---|---|
| Supplier | R&D Systems |
| Catalog | 6634-KR |
| Category | Protein |
| Prices | $329.00 |
| Sizes | 50 µg |
| Species Reactivities | Human |
| Nature | Recombinant |
| Source | Mouse myeloma cell line, NS0-derived Human KIR2DL5 (His22 - His240) Accession # NP_065396 IEGRMD Human IgG 1 (Pro100 - Lys330) N-terminus C-terminus |
| Purity | >95%, by SDS-PAGE under reducing conditions and visualized by silver stain |
| Bioactivity | Measured by its ability to bind HLA on MDA‑MB‑231 human breast cancer cells. The ED 50 for this effect is 0.9-3.6 μg/mL. Optimal dilutions should be determined by each laboratory for each application. |
| Endotoxin | <0.10 EU per 1 μg of the protein by the LAL method. |
| SwissProt/Accession | NP_065396 |
| Gene | KIR2DL5A |
| Sequence | His22 |
| Supplier Page | Shop |